| abstract |
The compound of formula (I), or a pharmaceutically acceptable salt, solvate, stereoisomer and / or hydrate thereof, wherein: Q is a phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl ring, and R 9, R 10 and R 11 are each independently selected among hydrogen, C1-4alkyl, O (C1-4alkyl), halogen, haloC1-4alkyl, cyano, SO2 (C1-4alkyl), and / or nitro; R6 is C1-6alkyl or cyclopropyl; R 2 is selected from C 1-4 alkyl, NR 7 R 8, and C 1-4 alkyl is substituted by the group NR 7 R 8; and R 7 and R 8 are each independently selected from hydrogen, C 1-6 alkyl and C 3-6 cycloalkyl, each of the groups R 7 and R 8 being optionally substituted with one to two OH, O (C 1-4 alkyl), imidazolyl, pyridyl, phenyl, tetrahydrofuryl, NH2, NH (C1-4alkyl), N (C1-4alkyl) 2 and N-morpholinyl, or alternatively, R7 and R8 together with the nitrogen atom to which they are attached form a morpholinyl, piperidinyl or piperazinyl ring. The patent contains 13 more patent claims. |